journal article·2020-11

Use of bioactive extracellular matrix fragments as a urethral bulking agent to treat stress urinary incontinence

Ying Wang, Meng Duan, Mahbubur Rahman, Ming Yang, Weixin Zhao, Shukui Zhou, Guo Gao, Qiang Fu

Acta Biomaterialia· Volume 117
Publisher page

Abstract

Injection of urethral bulking agents is a low-risk, minimally invasive surgical procedure to treat stress urinary incontinence (SUI). In this study, we developed a promising injectable bulking agent comprising extracellular matrix fragments of adipose-derived stem cell sheets (ADSC ECM) and investigated its effectiveness in urethral bulking therapy. The structural integrity and proteins of ADSC sheet ECM were well retained in decellularized ADSC ECM fragments. To locate transplanted ADSC ECM fragments, they were labeled with ultrasmall super-paramagnetic iron oxide nanoparticles, which enabled in vivo monitoring after implantation in a SUI rat model for up to 4 weeks. When ADSC ECM fragments were injected into the rat urethra, they became fully integrated with the surrounding tissue within 1 week. Four weeks after transplantation, host cells had regenerated within the ADSC ECM fragment injection area. Moreover, new smooth muscle tissue had formed around the ADSC ECM fragments, as confirmed by positive staining of myosin. These results indicate that injection of ECM fragments may be a promising minimally invasive approach for treating SUI.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Urological Disorders and Treatments · Hernia repair and management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (63)

Show source-provided references
1. The prevalence and severity of urinary incontinence in women10.1136/jech.35.1.71 ↗
2. Effect of electromyographic biofeedback as an add-on to pelvic floor muscle exercises on neuromuscular outcomes and quality of life in postmenopausal women with stress urinary incontinence: a randomized controlled trial10.1002/nau.23258 ↗
3. Biofeedback for pelvic floor muscle training in women with stress urinary incontinence: a systematic review with meta-analysis10.1016/j.physio.2018.07.012 ↗
4. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women
5. Particulate versus non-particulate bulking agents in the treatment of stress urinary incontinence
6. A randomized comparison of a single-incision midurethral sling and a transobturator midurethral sling in women with stress urinary incontinence: results of 12-mo follow-up10.1016/j.eururo.2014.07.027 ↗
7. The use of a vaginal pessary to decide whether a mid urethral sling should be added to prolapse surgery10.1097/JU.0000000000000575 ↗
8. Robot-assisted AMS-800 artificial urinary sphincter bladder neck implantation in female patients with stress urinary incontinence10.1016/j.eururo.2018.07.036 ↗
9. Robot-assisted implantation of an artificial urinary sphincter, the AMS-800, via a posterior approach to the bladder neck in women with intrinsic sphincter deficiency10.1111/bju.14884 ↗
10. How cure rates drive patients' preference for urethral bulking agent or mid-urethral sling surgery as therapy for stress urinary incontinence10.1002/nau.23997 ↗
11. Patient characteristics that may influence the effect of urethral injection therapy for female stress urinary incontinence10.1097/JU.0000000000000176 ↗
12. Local tissue reaction to the subureteral injection of glutaraldehyde cross-linked bovine collagen in humans10.1016/S0022-5347(17)40227-8 ↗
13. Complications of ethylene vinyl alcohol copolymer as an intraurethral bulking agent in men with stress urinary incontinence10.1016/j.urology.2007.10.016 ↗
14. Dual growth factor-loaded in situ gel-forming bulking agent: passive and bioactive effects for the treatment of urinary incontinence10.1007/s10856-014-5365-3 ↗
15. A bioactive injectable bulking material; a potential therapeutic approach for stress urinary incontinence10.1016/j.biomaterials.2019.03.030 ↗
16. Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering10.1016/j.biomaterials.2009.06.045 ↗
17. Decellularized heart ECM hydrogel using supercritical carbon dioxide for improved angiogenesis10.1016/j.actbio.2017.11.046 ↗
18. Extracellular matrix derived from chondrocytes promotes rapid expansion of human primary chondrocytes in vitro with reduced dedifferentiation10.1016/j.actbio.2018.12.006 ↗
19. Decellularized extracellular matrix-based bio-ink with enhanced 3D printability and mechanical properties10.1088/1758-5090/ab5d80 ↗
20. Extracellular matrix hydrogel derived from decellularized tissues enables endodermal organoid culture10.1038/s41467-019-13605-4 ↗
21. Directing the growth and alignment of biliary epithelium within extracellular matrix hydrogels10.1016/j.actbio.2018.12.039 ↗
22. Exploiting extracellular matrix-stem cell interactions: a review of natural materials for therapeutic muscle regeneration10.1016/j.biomaterials.2011.09.078 ↗
23. Hydrogel derived from porcine decellularized nerve tissue as a promising biomaterial for repairing peripheral nerve defects10.1016/j.actbio.2018.04.001 ↗
24. Effects of adipose stem cell sheets on colon anastomotic leakage in an experimental model: proof of principle10.1016/j.biomaterials.2017.06.011 ↗
25. Human fibroblast-derived ECM as a scaffold for vascular tissue engineering10.1016/j.biomaterials.2012.09.015 ↗
26. Cartilaginous extracellular matrix derived from decellularized chondrocyte sheets for the reconstruction of osteochondral defects in rabbits10.1016/j.actbio.2018.10.005 ↗
27. Adipose-derived stem cell sheets functionalized by hybrid baculovirus for prolonged GDNF expression and improved nerve regeneration10.1016/j.biomaterials.2017.05.004 ↗
28. Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction10.1093/cvr/cvm046 ↗
29. Yield of human adipose-derived adult stem cells from liposuction aspirates10.1080/14653240310004539 ↗
30. Molecular physiognomies and applications of adipose-derived stem cells10.1007/s12015-014-9578-0 ↗
31. Therapeutic efficacy-potentiated and diseased organ-targeting nanovesicles derived from mesenchymal stem cells for spinal cord injury treatment10.1021/acs.nanolett.8b01816 ↗
32. Cell sheet composed of adipose-derived stem cells demonstrates enhanced skin wound healing with reduced scar formation10.1016/j.actbio.2018.07.022 ↗
33. Decellularization of tissues and organs10.1016/j.biomaterials.2006.02.014 ↗
34. Decellularized and matured esophageal scaffold for circumferential esophagus replacement: proof of concept in a pig model10.1016/j.biomaterials.2018.05.023 ↗
35. Extracellular matrix scaffolds for cartilage and bone regeneration10.1016/j.tibtech.2012.12.004 ↗
36. The host immune response to tissue-engineered organs: current problems and future directions10.1089/ten.teb.2015.0376 ↗
37. Human adipose tissue is a source of multipotent stem cells10.1091/mbc.e02-02-0105 ↗
38. Multilineage potential of adult human mesenchymal stem cells10.1126/science.284.5411.143 ↗
39. Treatment of stress urinary incontinence with adipose tissue-derived stem cells10.3109/14653240903350265 ↗
40. Hydrogels derived from demineralized and decellularized bone extracellular matrix10.1016/j.actbio.2013.04.029 ↗
41. Two-photon fluorescence and second-harmonic generation imaging of collagen in human tissue based on multiphoton microscopy10.1002/sca.20219 ↗
42. Superparamagnetic Fe3O4-PEG2K-FA@Ce6 nanoprobes for in vivo dual-mode imaging and targeted photodynamic therapy10.1038/srep36187 ↗
43. One-year follow-up of tension-free vaginal tape (TVT) and trans-obturator suburethral tape from inside to outside (TVT-O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial10.1016/j.eururo.2006.10.066 ↗
44. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the trial of midurethral slings (TOMUS) study10.1016/j.ajog.2011.07.011 ↗
45. Incidence of vaginal erosion with different synthetic materials for suburethral sling in the treatment of stress urinary incontinence: a systematic review
46. Urethral bulking agents for female stress urinary incontinence10.1002/nau.23924 ↗
47. Nonsurgical outpatient therapies for the management of female stress urinary incontinence: long-term effectiveness and durability10.1155/2011/176498 ↗
48. Changing surgical trends for female stress urinary incontinence in England10.1007/s00192-018-3839-4 ↗
49. Massive prolapse of the urethral mucosa following periurethral injection of calcium hydroxylapatite for stress urinary incontinence10.1007/s00192-005-0038-x ↗
50. Foreign-body granuloma after injection of calcium hydroxylapatite for type III stress urinary incontinence10.1097/AOG.0b013e3182161953 ↗
51. Microfluidic production of bioactive fibrin micro-beads embedded in crosslinked collagen used as an injectable bulking agent for urinary incontinence treatment10.1016/j.actbio.2017.11.034 ↗
52. Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents10.1007/s00192-012-2011-9 ↗
53. Complications of urethral bulking therapy for female stress urinary incontinence
54. Magnetic cell-scaffold interface constructed by superparamagnetic IONP enhanced osteogenesis of adipose-derived stem cells10.1021/acsami.8b17427 ↗
55. MR and PET-CT monitoring of tissue-engineered vascular grafts in the ovine carotid artery10.1016/j.biomaterials.2019.119228 ↗
56. The effect of nonuniform magnetic targeting of intracoronary-delivering mesenchymal stem cells on coronary embolisation10.1016/j.biomaterials.2013.08.092 ↗
57. Long-term MRI tracking of dual-labeled adipose-derived stem cells homing into mouse carotid artery injury
58. Bioactive porous beads as an injectable urethral bulking agent: in vivo animal study for the treatment of urinary incontinence10.1089/ten.tea.2010.0600 ↗
59. Macro/nano-gel composite as an injectable and bioactive bulking material for the treatment of urinary incontinence10.1021/bm401787u ↗
60. Functional recovery of urethra by plasmid DNA-loaded injectable agent for the treatment of urinary incontinence10.1016/j.biomaterials.2013.03.045 ↗
61. Applicability of regenerative medicine and tissue engineering for the treatment of stress urinary incontinence in female patients
62. Periurethral injection of sustained release basic fibroblast growth factor improves sphincteric contractility of the rat urethra denervated by botulinum-a toxin10.1016/j.juro.2006.03.070 ↗
63. Increased urethral resistance by periurethral injection of low serum cultured adipose-derived mesenchymal stromal cells in rats10.1111/j.1442-2042.2011.02795.x ↗